Question 1

Has Walter Berkowitz received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,285 in general payments to Walter Berkowitz across 104 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Walter Berkowitz did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Walter Berkowitz come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Novartis	33	$351
AstraZeneca	8	$155
Johnson & Johnson	17	$133
Sanofi-aventis U.S. LLC	9	$123
Boston Scientific	5	$75
Amgen	6	$75
Vifor Pharma, Inc.	4	$50
Atricure, Inc.	2	$48
Bayer	2	$30
Boehringer Ingelheim	2	$29
Pfizer	2	$28
Regeneron Healthcare Solutions, Inc.	2	$28
Gilead	2	$27
E.r. Squibb & Sons, L.L.C.	2	$24
Portola Pharmaceuticals, LLC	2	$23
Abbott	1	$18
Amarin Pharma, Inc.	1	$16
Kowa Pharmaceuticals America, Inc.	1	$15
Aegerion Pharmaceuticals, Inc.	1	$14
Lundbeck LLC	1	$12
Medicure Pharma Inc.	1	$11

Walter Berkowitz

Payments from drug & device makers

Who reported the general payments

How this compares

Other cardiovascular disease in Fort Lee